Abstract
This article sought to analyze the innovation ecosystems in health, countries that develop them and the theoretical models they resort to. To this end, three databases carried out a systematic review through a bibliographic search in English, Spanish and Portuguese. 40% of health innovation ecosystems are in the USA, 13% in South Africa, 10% in the UK, 6.67% in Namibia, and 30% in various countries. Of the theoretical models used, 13% resort to the quadruple helix, open innovation 13%, the triple helix 10%, and ehealth 7%. The USA concentrated the development of innovation ecosystems. Quadruple helix and open innovation, were the theorical models frequently used, both includes society as part of its implementation.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference37 articles.
1. Innovation in Healthcare Delivery Systems: A Conceptual Framework.;V Omachonu;Innov. J. Public Sect. Innov. J.,2010
2. Business model innovation and business concept innovation as the context of incremental innovation and radical innovation.;J Souto;Tour. Manag.,diciembre de 2015
3. Innovation to strengthen growth and address global and social challenges.,2012
4. A multi-level perspective on innovation ecosystems for path-breaking innovation.;B Walrave;Technol. Forecast. Soc. Change.,noviembre de 2018
5. Charting the Innovation Ecosystem.;M Gobble;Res. Technol. Manag.,2014